国际中文开源期刊平台

论我国药品鉴定制度之构建与完善

Construction and Improvement of Drug Identification System in China

刑事司法科学与治理 / 2021,2(1)：129-135 / 2021-06-23 408 314

查看全文 下载文档

• 作者： 王炜      张梦涛     
• 单位：

  甘肃政法大学公安分院，兰州

• 关键词： 药品侵权；药害事故；药品鉴定
• Drug infringement; Drug accident; Drug identification
• 摘要： 为解决当前我国药品侵权纠纷中存在的原、被告及利益相关主体权责严重失衡的问题，以药品侵权诉讼中的常见被告——药品生产者为视角，通过总结相关学术理论，收集审判实践数据，对比并借鉴域外药品管理与诉讼制度，从而进一步完善我国药害事故中药品生产者的诸多权利，进而使我国药品鉴定制度得到强化与发展。
• In order to solve the serious imbalance between the rights and responsibilities of the plaintiff, the defendant and the stakeholders in the current drug infringement disputes in China, from the perspective of drug producers, a common defendant in drug infringement litigation, this paper summarizes relevant academic theories, collects trial practice data, compares and draws lessons from foreign drug management and litigation systems, so as to further improve the rights of drug producers in drug accidents in China, and then strengthen and develop the drug identification system in China.
• DOI： https://doi.org/10.35534/cjsg.0201017
• 引用： 王炜，张梦涛．论我国药品鉴定制度之构建与完善［J］．刑事司法科学与治理，2021，2（1）：129-135．